Corevitas
Clinical trials sponsored by Corevitas, explained in plain language.
-
New vitiligo registry aims to uncover disease trends in 2,500 patients
Knowledge-focused ENROLLING_BY_INVITATIONThis observational registry will follow 2,500 adults and adolescents with nonsegmental vitiligo to understand how the disease presents and progresses over time. Participants continue their usual care with a dermatologist. No experimental treatment is given; the goal is to collect…
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
10,000-Person study to track how obesity drugs really work
Knowledge-focused ENROLLING_BY_INVITATIONThis registry will follow 10,000 people with obesity who are taking or starting standard weight-loss medications. Researchers will collect data on how well the drugs work and any side effects over time. The goal is to understand the real-world benefits and risks of these treatmen…
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
New registry tracks Alzheimer's patients to improve care
Knowledge-focused ENROLLING_BY_INVITATIONThis study is a registry that collects information from about 2,000 people with mild cognitive impairment or Alzheimer's disease. Researchers will track how the disease progresses and how treatments work in real-world settings. The goal is to better understand Alzheimer's and imp…
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Massive arthritis registry aims to unlock secrets of best treatments
Knowledge-focused ENROLLING_BY_INVITATIONThis study is a large registry that will follow 5,000 people with psoriatic arthritis or spondyloarthritis across North America. Researchers will collect information on how different approved treatments work and their side effects over time. The goal is to better understand these…
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
10,000 eczema patients enrolled in landmark Long-Term safety study
Knowledge-focused ENROLLING_BY_INVITATIONThis registry will follow 10,000 adults with atopic dermatitis (eczema) who are already using approved treatments. Researchers will collect data on how well the treatments work and any side effects over time. The goal is to better understand the disease, its complications, and cu…
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
3,000 RA patients to donate blood for future breakthroughs
Knowledge-focused ENROLLING_BY_INVITATIONThis study is building a large collection of blood samples from 3,000 people with rheumatoid arthritis. Researchers will use these samples to look for biomarkers that could help predict disease activity or treatment side effects. Participants must already be in a registry and sta…
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Massive MS registry launches to track Real-World treatment outcomes
Knowledge-focused ENROLLING_BY_INVITATIONThis study is a registry that will follow about 1,000 adults with multiple sclerosis (MS) who are starting a new MS medication. Researchers will collect information on side effects, relapses, and daily function over time to compare how well different treatments work in real life.…
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
800 NMOSD patients join landmark registry to unlock disease secrets
Knowledge-focused ENROLLING_BY_INVITATIONThis observational study will follow about 800 adults with neuromyelitis optica spectrum disorder (NMOSD) across North America. Researchers will collect data on how the disease presents, progresses, and is managed in real-world settings. No experimental treatments are given; the …
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
10,000 psoriasis patients enrolled to uncover hidden risks of new therapies
Knowledge-focused ENROLLING_BY_INVITATIONThis registry is following 10,000 adults with psoriasis treated by dermatologists across North America. Researchers are collecting data on side effects, disease severity, and overall health to compare the safety of approved treatments, including newer biologic drugs. The goal is …
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
New registry to track MG drug safety in 1,500 patients
Knowledge-focused ENROLLING_BY_INVITATIONThis registry will follow about 1,500 adults with myasthenia gravis (MG) to see how well current treatments work and how safe they are in real life. Doctors and patients will report data during routine visits. The goal is to better understand the disease and improve care.
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
91,000-Patient registry reveals how RA drugs really perform
Knowledge-focused ENROLLING_BY_INVITATIONThis registry follows over 91,000 people with rheumatoid arthritis to see how well approved treatments work and how safe they are in everyday use. Researchers collect data from rheumatologists across North America, including details on disease patterns and other health conditions…
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
2000 RA patients enrolled in Real-World drug safety study
Knowledge-focused OngoingThis observational registry follows 2000 Japanese adults with rheumatoid arthritis to see how well different approved medications work and what side effects occur in everyday medical practice. Researchers will track joint pain, swelling, and serious health events like infections …
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Thousands of IBD patients enrolled in massive north american registry
Knowledge-focused ENROLLING_BY_INVITATIONThis registry is following over 2,200 adults with inflammatory bowel disease (IBD) across North America to see how approved treatments work in everyday practice. Researchers are collecting data on disease patterns, complications, and patient outcomes. The goal is to better unders…
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC